Divi's Laboratories Limited (DIVISLAB.NS)
NSE - NSE Real-time price. Currency in INR
Add to watchlist
At close: 03:30PM IST
| Previous close | 4,479.70 |
| Open | 4,486.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 4,439.70 - 4,522.25 |
| 52-week range | 3,295.30 - 4,627.95 |
| Volume | |
| Avg. volume | 623,822 |
| Market cap | 1.196T |
| Beta (5Y monthly) | 0.38 |
| PE ratio (TTM) | 74.47 |
| EPS (TTM) | 60.48 |
| Earnings date | 12 Aug 2024 - 16 Aug 2024 |
| Forward dividend & yield | 30.00 (0.67%) |
| Ex-dividend date | 01 Aug 2024 |
| 1y target est | 4,951.17 |
Yahoo Finance UKHow to invest in the Indian stock market
India’s stock market capitalisation topped $4.3tn to overtake Hong Kong as the world’s fourth-largest market.
- Reuters
India's Divi's Labs Q1 profit slumps on drug pricing pressures
Indian pharmaceutical company Divi's Laboratories reported a 49.2% fall in quarterly profit, missing analysts' estimates, as the generic drug maker grappled with pricing pressures in key markets like the United States. The company reported a consolidated profit of 3.56 billion rupees ($42.9 million) for the first quarter ended June 30, compared to 7.02 billion rupees a year ago. Analysts, on an average, had expected a profit of 4.17 billion rupees, according to Refinitiv data.
© 2024 Yahoo. All rights reserved.